Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 551,600 | 566,000 | 397,000 | 404,000 | 573,310 |
| Marketable Securities | 287,570 | 84,000 | 85,000 | 91,000 | 87,840 |
| Receivables | 1,043,580 | 773,000 | 759,000 | 739,000 | 988,130 |
| Inventories | 1,299,590 | 1,240,000 | 1,244,000 | 1,275,000 | 1,196,220 |
| Other current assets | 84,180 | 274,000 | 231,000 | 327,000 | 118,580 |
| TOTAL | $3,266,520 | $2,937,000 | $2,716,000 | $2,836,000 | $2,964,080 |
| Non-Current Assets | |||||
| Investments And Advances | 154,640 | 151,000 | 125,000 | 134,000 | 147,460 |
| Other Non-Current Assets | 256,000 | 259,000 | 229,000 | 204,000 | 207,400 |
| TOTAL | $410,640 | $410,000 | $354,000 | $338,000 | $354,860 |
| Total Assets | $7,007,320 | $6,495,000 | $6,118,000 | $6,345,000 | $6,251,310 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 250,500 | 160,000 | 193,000 | 178,000 | 177,180 |
| Accrued Expenses | 112,890 | 0 | 0 | 0 | 105,370 |
| Other current liabilities | 1,162,480 | 1,148,000 | 1,045,000 | 965,000 | 848,520 |
| TOTAL | $1,767,020 | $1,507,000 | $1,450,000 | $1,294,000 | $1,215,760 |
| Non-Current Liabilities | |||||
| Long Term Debt | 208,410 | 206,000 | 206,000 | 217,000 | 198,390 |
| aiOther Non-Current Liabilities | 108,710 | 95,000 | 93,000 | 93,000 | 101,530 |
| TOTAL | $625,400 | $690,000 | $514,000 | $578,000 | $609,370 |
| Total Liabilities | $2,392,440 | $2,197,000 | $1,964,000 | $1,872,000 | $1,825,140 |
| Shareholders' Equity | |||||
| Common Shares | 118,400 | 115,000 | 114,000 | 123,000 | 118,400 |
| Retained earnings | 4,502,650 | 4,192,000 | 4,070,000 | 4,308,000 | 3,786,050 |
| Other shareholders' equity | 3,820 | 1,000 | -21,000 | 50,000 | 101,360 |
| TOTAL | $4,614,870 | $4,298,000 | $4,154,000 | $4,473,000 | $4,426,160 |
| Total Liabilities And Equity | $7,007,310 | $6,495,000 | $6,118,000 | $6,345,000 | $6,251,300 |